会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 102. 发明专利
    • BRPI0409209A
    • 2006-03-28
    • BRPI0409209
    • 2004-04-06
    • BASF PLANT SCIENCE GMBH
    • CIRPUS PETRABAUER JOERGMEYER ASTRIDHEINZ ERNSTZOHRINGER ULRICH
    • C12N9/02C12N15/82C12N15/00C12P7/64A01H1/00A01K67/00A23D9/00A23K1/16
    • The present invention relates to an improved process for the specific preparation of unsaturated omega-3 fatty acids, and to a process for preparing triglycerides having an increased content of unsaturated fatty acids, particularly of omega-3 fatty acids having more than three double bonds. The invention relates to the preparation of a transgenic organism, preferably a transgenic plant or a transgenic microorganism, having increased content of fatty acids, oils or lipids having Delta-4 double bonds owing to the expression of a Delta-4-desaturase from Euglena gracilis. The invention additionally relates to expression cassettes comprising a nucleic acid sequence, a vector and organisms comprising at least one nucleic acid sequence or one expression cassette. The invention additionally relates to unsaturated fatty acids and to triglycerides having an increased content of unsaturated fatty acids and to the use thereof. Fatty acids and triglycerides have a large number of uses in the food industry, in animal nutrition, cosmetics and in the drugs sector. They are suitable for a wide variety of uses depending on whether they are free saturated or unsaturated fatty acids or triglycerides having an increased content of saturated or unsaturated fatty acids.
    • 103. 发明专利
    • Fremgangsmåte for fremstilling av flerumettede fettsyrer i transgene organismer.
    • NO20181488A1
    • 2006-02-24
    • NO20181488
    • 2018-11-21
    • BASF PLANT SCIENCE GMBH
    • HEINZ ERNSTSPERLING PETRACIRPUS PETRADOMERGUE FREDERICZANK THORSTENBAUER JÖRGQIU ZIAOVRINTEN PATRICIAMEYER ASTRIDKIRSCH JELENAABBADI AMINE
    • A23D9/00A23D9/02A23L33/115C11B1/00C11B1/02C12N9/02C12N9/10C12N15/82C12P7/64
    • Foreliggende oppfinnelse angår en fremgangsmåte for produksjon av flerumettede fettsyrer i en organisme ved innføring i organismen, nukleinsyrer som koder for polypeptider med Δ5-elongase-aktivitet. Fordelaktig kan disse nukleinsyresekvenser uttrykkes i organismen, hvis det passer sammen med ytterligere nukleinsyresekvenser som koder for polypeptider av biosyntese av fettsyre- eller lipid-metabolisme. Spesielt fordelaktig er nukleinsyresekvenser som koder for en Δ6-desaturase-, Δ5-desaturase-, Δ4-desaturase- og/eller Δ6-elongase-aktivitet. Disse desaturaser og elongaser er fordelaktig avledet fra Thalassiosira, Euglena eller Ostreococcus. Oppfinnelsen angår videre en fremgangsmåte for fremstilling av oljer og/eller triacylglycerider med et forhøyet innhold av langkjedede flerumettede fettsyrer. I en foretrukket utførelsesform angår foreliggende oppfinnelse videre en metode for fremstilling av umettede ω3-fettsyrer og en metode for fremstilling av triglycerider med et forhøyet innhold av umettede fettsyrer, spesielt ω3-fettsyrer med mer enn tre dobbeltbindinger. Oppfinnelsen angår dannelse av en transgen organisme, fortrinnsvis en transgen plante eller en transgen mikroorganisme, med et forhøyet innhold av umettet ω3-fettsyrer, oljer eller lipider med ω3-dobbeltbindinger som resultat av ekspresjon av elongaser og desaturaser anvendt ved fremgangsmåten ifølge oppfinnelsen, fordelaktig sammen med ω3-desaturaser, for eksempel en ω3-desaturase fra sopper av familien Pythiaceae så som slekten Phytophthora, for eksempel slekten og arten Phytophthora infestans eller en ω3-desaturase fra alger så som familien Prasinophyceae, for eksempel slekten Ostreococcus, spesifikt slekten og arten Ostreococcus tauri eller diatoméer så som slekten Thalassiosira, spesifikt slekten og arten Thalassiosira pseudonana. Oppfinnelsen angår videre nukleinsyresekvenser, nukleinsyrekonstruksjoner, vektorer og organismer omfattende nukleinsyresekvensene ifølge oppfinnelsen, vektorer omfattende nukleinsyresekvensene og/eller nukleinsyrekontruksjonene og transgene organismer omfattende de ovennevnte nukleinsyresekvenser, nukleinsyrekonstruksjoner og/eller vektorer. En ytterligere del av oppfinnelsen angår oljer, lipider og/eller fettsyrer produsert ved fremgangsmåten ifølge oppfinnelsen og anvendelse av dem. Oppfinnelsen angår videre umettede fettsyrer og triglycerider med et forhøyet innhold av umettede fettsyrer og anvendelse av dem.
    • 104. 发明专利
    • NO20054372L
    • 2005-12-19
    • NO20054372
    • 2005-09-21
    • BASF PLANT SCIENCE GMBH
    • HEINZ ERNSTZAHRINGER ULRICHCIRPUS PETRABAUER JORGMEYER ASTRID
    • C12N9/02A01H1/00A01K67/00A23D9/00A23K1/16C12N15/82C12P7/64
    • The present invention relates to an improved process for the specific preparation of unsaturated omega-3 fatty acids, and to a process for preparing triglycerides having an increased content of unsaturated fatty acids, particularly of omega-3 fatty acids having more than three double bonds. The invention relates to the preparation of a transgenic organism, preferably a transgenic plant or a transgenic microorganism, having increased content of fatty acids, oils or lipids having Delta-4 double bonds owing to the expression of a Delta-4-desaturase from Euglena gracilis. The invention additionally relates to expression cassettes comprising a nucleic acid sequence, a vector and organisms comprising at least one nucleic acid sequence or one expression cassette. The invention additionally relates to unsaturated fatty acids and to triglycerides having an increased content of unsaturated fatty acids and to the use thereof. Fatty acids and triglycerides have a large number of uses in the food industry, in animal nutrition, cosmetics and in the drugs sector. They are suitable for a wide variety of uses depending on whether they are free saturated or unsaturated fatty acids or triglycerides having an increased content of saturated or unsaturated fatty acids.
    • 106. 发明专利
    • METHOD FOR THE PRODUCTION OF MULTIPLY-UNSATURATED FATTY ACIDS IN TRANSGENIC ORGANISMS
    • CA2998666A1
    • 2005-02-10
    • CA2998666
    • 2004-07-16
    • BASF PLANT SCIENCE GMBH
    • ZANK THORSTENBAUER JORGCIRPUS PETRAABBADI AMINEHEINZ ERNSTQIU XIAOVRINTEN PATRICIASPERLING PETRADOMERGUE FREDERICMEYER ASTRIDKIRSCH JELENA
    • C12N15/53A01H5/00A23D9/00A23K20/158A23L33/115A61K8/36A61K31/202C11B1/02C12N5/10C12N9/00C12N9/02C12N9/10C12N15/52C12N15/82C12P7/64
    • Producing polyunsaturated fatty acids (I) comprises introducing nucleic acid sequences coding for delta 9 elongase or delta 6 desaturase, delta 8 desaturase or delta 6 elongase, delta 5 desaturase, delta 5 elongase and delta 4 desaturase activity into an organism to produce a transgenic organism whose total lipids include at least 1 wt.% (I). Producing polyunsaturated fatty acids of formula (I) comprises introducing nucleic acid sequences coding for delta 9 elongase or delta 6 desaturase, delta 8 desaturase or delta 6 elongase, delta 5 desaturase, delta 5 elongase and delta 4 desaturase activity into an organism to produce a transgenic organism whose total lipids include at least 1 wt.% of formula (I). [Image] R 1>OH, coenzyme A (thioester), lysophosphatidyl choline, lysophosphatidyl ethanolamine, lysophosphatidyl glycerol, lysophosphatidyl serine, lysophosphatidyl inositol, sphingobase or OCH 2CH(OR 3>)CH 2OR 2>; R 2>H, lysophosphatidyl choline, lysophosphatidyl ethanolamine, lysophosphatidyl glycerol, lysophosphatidyl serine, lysophosphatidyl inositol, (un)saturated 2-24C alkylcarbonyl or CO(CH 2) n(CH=CHCH 2) m(CH 2) pCH 3; R 3>H, (un)saturated 2-24C alkylcarbonyl or CO(CH 2) n(CH=CHCH 2) m(CH 2) pCH 3; n : 2-9; m : 2-6; p : 0 or 3. Independent claims are also included for: (1) oils, lipids or fatty acids produced as above; (2) oil, lipid or fatty acid composition that comprises polyunsaturated fatty acids produced as above and is derived from transgenic plants; (3) isolated nucleic acid sequence coding for a delta 5 elongase polypeptide having one of 6 amino acid sequences given in the specification; (4) isolated nucleic acid sequence that codes for a delta 6 elongase polypeptide and has one of 4 nucleotide sequences given in the specification; (5) isolated nucleic acid sequence that codes for a omega 3 desaturase polypeptide and has one of 2 nucleotide sequences given in the specification; (6) isolated nucleic acid sequence that codes for a delta 6 desaturase polypeptide and has one of 2 nucleotide sequences given in the specification; (7) isolated nucleic acid sequence that codes for a delta 5 desaturase polypeptide and has one of 4 nucleotide sequences given in the specification; (8) isolated nucleic acid sequence that codes for a delta 4 desaturase polypeptide and has one of 2 nucleotide sequences given in the specification; (9) isolated nucleic acid sequence that codes for a delta 12 desaturase polypeptide and has one of 2 nucleotide sequences given in the specification; (10) amino acid sequence encoded by an isolated nucleic acid sequence as above; (11) genetic construct comprising an isolated nucleic acid as above linked to one or more regulatory signals; (12) vector containing a nucleic acid or construct as above; (13) transgenic non-human organism containing a nucleic acid, construct or vector as above.